参考文献/References:
[1] Putz Z, Tabák AG, Tóth N,et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance[J].Diabetes Care,2009,32(1):181-183. DOI:10.2337/dc08-1406.
[2] Schwarz P, Brunswick P, Calvet JH, et al. EZSCANTM a new technology to detect diabetes risk[J]. Br J Diab Vasc Dis, 2011,11(11): 204-209.DOI:10.1177/1474651411402629.
[3] Casellini CM, Parson HK, Richardson MS, et al. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction[J].Diabetes Technol Ther,2013,15(11):948-953. DOI:10.1089/dia.2013.0129.
[4] Yajnik CS, Kantikar VV, Pande AJ, et al. Quick and simple evaluation of sudomotor function for screening of diabetic neuropathy[J].ISRN Endocrinol,2012,2012:103714. DOI:10.5402/2012/103714.
[5] Gin H, Baudoin R, Raffaitin CH, et al. Non-invasive and quantitative assessment of sudomotor function for peripheral diabeticneuropathy evaluation[J].Diabetes Metab,2011,37(6):527-532. DOI:10.1016/j.diabet.2011.05.003.
[6] Mao F, Liu S, Qiao X,et al. Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients[J].J Diabetes Investig,2017,8(3):363-368. DOI:10.1111/jdi.12575.
[7] Eranki VG, Santosh R, Rajitha K, et al. Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes[J].Diabetes Res Clin Pract,2013,101(3):e11-e13. DOI:10.1016/j.diabres.2013.07.003.
[8] Smith AG, Lessard M, Reyna S,et al. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy[J].J Diabetes Complications,2014,28(4):511-516. DOI:10.1016/j.jdiacomp.2014.02.013.
[9] Gandecka A, Araszkiewicz A, Piaciński S,et al. Evaluation of sudomotor function in adult patients with longlasting type 1 diabetes[J].Pol Arch Intern Med,2017,127(1):16-24. DOI:10.20452/pamw.3884.
[10] Selvarajah D, Cash T, Davies J,et al. SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy[J].PLoS One,2015,10(10):e0138224. DOI:10.1371/journal.pone.0138224.
[11] 黄雪,沈白玉,刘彦君.SUDOSCAN仪筛查2型糖尿病患者肾脏病变应用研究[J]. 河北医科大学学报, 2016,37(5): 510-515. DOI:10.3969/j.issn.1007-3205.2016.05.004.
[12] Luk AO, Fu WC, Li X, et al.The clinical utility of SUDOSCAN in chronic kidney disease in Chinese patients with type 2 diabetes[J].PLoS One,2015,10(8):e0134981. DOI:10.1371/journal.pone.0134981.
[13] Freedman BI, Bowden DW, Smith SC,et al. Relationships between electrochemical skin conductance and kidney disease in type 2 diabetes[J]. J Diabetes Complications,2014,28(1):56-60.DOI:10.1016/j.jdiacomp.2013.09.006.
[14] Freedman BI, Smith SC, Bagwell BM, et al. Electrochemical skin conductance in diabetic kidney disease[J].Am J Nephrol,2015,41(6):438-447. DOI:10.1159/000437342.
[15] Ozaki R, Cheung KK, Wu E, et al. A new tool to detect kidney disease in Chinese type 2 diabetes patients: comparison of EZSCAN with standard screening methods[J].Diabetes Technol Ther,2011,13(9):937-943. DOI:10.1089/dia.2011.0023.
[16] Sheshah E, Madanat A, Al-Greesheh F,et al. Electrochemical skin conductance to detect sudomotor dysfunction, peripheral neuropathy and the risk of foot ulceration among Saudi patients with diabetes mellitus[J].J Diabetes Metab Disord,2016,15:29. DOI:10.1186/s40200-016-0252-8.
[17] Névoret ML, Vinik AI. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test[J].J Diabetes Complications,2015,29(2):313-317.DOI:10.1016/j.jdiacomp.2014.10.012.
[18] Calvet JH, Dupin J, Winiecki H, et al. Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic[J].Exp Clin Endocrinol Diabetes,2013,121(2):80-83. DOI:10.1055/s-0032-1323777.
相似文献/References:
[1]毛斐,鹿斌,李益明.SUDOSCAN对糖尿病周围神经病变的诊断价值[J].国际内分泌代谢杂志,2016,36(05):331.[doi:10.3760/cma.j.issn.1673-4157.2016.05.12]
Mao Fei,Lu Bin,Li Yiming.Diagnostic value of SUDOSCAN in detecting diabetic peripheral neuropathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):331.[doi:10.3760/cma.j.issn.1673-4157.2016.05.12]
[2]沙宇菁,李彦彦,杨玲.白脂素与2型糖尿病及其血管并发症的研究进展[J].国际内分泌代谢杂志,2021,41(02):133.[doi:10.3760/cma.j.cn121383-20200603-06007]
Sha Yujing,Li Yanyan,Yang Ling.Research progress of asprosin in type 2 diabetes mellitus and its vascular complications[J].International Journal of Endocrinology and Metabolism,2021,41(06):133.[doi:10.3760/cma.j.cn121383-20200603-06007]
[3]俞璐,王倩,许岚.甲皱襞毛细血管镜在糖尿病微血管并发症筛查中的应用[J].国际内分泌代谢杂志,2022,42(03):203.[doi:10.3760/cma.j.cn121383-20210621-06054]
Yu Lu,Wang Qian,Xu Lan..Application of nailfold capillaroscopy in the screening of diabetic microvascular complications[J].International Journal of Endocrinology and Metabolism,2022,42(06):203.[doi:10.3760/cma.j.cn121383-20210621-06054]
[4]李丽,曹明明.坏死性凋亡与糖尿病及慢性微血管并发症关系的研究进展[J].国际内分泌代谢杂志,2023,43(03):233.[doi:10.3760/cma.j.cn121383-20220226-02065]
Li Li,Cao Mingming..Research progress on the relationship between necroptosis and diabetes mellitus and chronic microvascular complications[J].International Journal of Endocrinology and Metabolism,2023,43(06):233.[doi:10.3760/cma.j.cn121383-20220226-02065]